000			01402 a2200409 4500
005			20250514002804.0
264		0	_c20010913
008			200109s 0 0 eng d
022			_a0008-6312
024	7		_a10.1159/000047346 _2doi
040			_aNLM _beng _cNLM
100	1		_aCallahan, K P
245	0	0	_aPlatelet function and fibrinolytic agents: two sides of a coin? _h[electronic resource]
260			_bCardiology _c2001
300			_a55-60 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aFibrinolytic Agents _xadverse effects
650	0	4	_aHumans
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aPlasminogen Activators _xadverse effects
650	0	4	_aPlatelet Activation _xdrug effects
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aRecombinant Proteins _xadverse effects
650	0	4	_aStreptokinase _xadverse effects
650	0	4	_aTenecteplase
650	0	4	_aThrombolytic Therapy _xadverse effects
650	0	4	_aTissue Plasminogen Activator _xadverse effects
700	1		_aMalinin, A I
700	1		_aGurbel, P A
700	1		_aAlexander, J H
700	1		_aGranger, C B
700	1		_aSerebruany, V L
773	0		_tCardiology _gvol. 95 _gno. 2 _gp. 55-60
856	4	0	_uhttps://doi.org/10.1159/000047346 _zAvailable from publisher's website
999			_c11353287 _d11353287